Plasma protein binding displacement interactions—why are they still regarded as clinically important?
- 1 February 1994
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 37 (2) , 125-128
- https://doi.org/10.1111/j.1365-2125.1994.tb04251.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Aspirin alters methotrexate disposition in rheumatoid arthritis patientsArthritis & Rheumatism, 1991
- Pharmacokinetic Consequences of Drug Displacement from Blood and Tissue ProteinsClinical Pharmacokinetics, 1984
- Protein Binding Displacement Interactions and their Clinical ImportanceDrugs, 1983
- Kinetics of drug displacement interactionsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Stereoselective Interaction of Phenylbutazone with [12C/13C]Warfarin Pseudoracemates in ManJournal of Clinical Investigation, 1980
- Stereoselective Interaction of Trimethoprim-Sulfamethoxazole with the Separated Enantiomorphs of Racemic Warfarin in ManNew England Journal of Medicine, 1980
- Plasma Protein Displacement Interactions Are Rarely of Clinical SignificancePharmacology, 1979
- Drug Interactions with Oral Sulphonylurea Hypoglycaemic DrugsDrugs, 1977
- Effect of phenylbutazone on the binding of vitamin K antagonists to albuminEuropean Journal of Clinical Pharmacology, 1973
- KINETICS AND CLINICAL IMPORTANCE OF DISPLACEMENT OF WARFARIN FROM ALBUMIN BY ACIDIC DRUGS*Annals of the New York Academy of Sciences, 1971